Skip to main content
Premium Trial:

Request an Annual Quote

Seahorse Bioscience Taps Research Instruments as SE Asia Distributor

NEW YORK (GenomeWeb News) – Seahorse Bioscience, a maker of cellular bioenergetic measurement tools, said today that it has named Research Instruments to distribute its products in Southeast Asia.

Singapore-based Research Instruments will distribute Seahorse's XF Extracellular Flux Analyzers, which provide a kinetic method for measuring the mitochondrial and glycolysis energy-producing pathways in a microplate.

The Billerica, Mass-based company's XF Analyzers are used to assess the impact of disease, drugs, genetic manipulations, and environmental effects on cells by monitoring the rate at which they consume oxygen and produce metabolic by-products, which identifies mitochondrial dysfunction and changes in cell metabolism.

Seahorse's VP of Sales and Marketing Steve Chomicz said in a statement that the partnership with Research Instruments will enable the company "to accelerate our sales in Singapore, Malaysia, and Thailand, as they have existing relationships with our ideal customer base."

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.